Patients and methods
T2-T3b N0M0 BCa, chronic kidney disease
From January 2014 to December 2019, out of 243 patients indicated for RC, 200 patients with T2-T3b N0M0 BCa were included in the current study after signing an informed consent. Patients indicated for palliative cystectomy, those with grossly enlarged LNS in MSCT or MRI, those with chronic kidney disease and who refused to participate in the study were excluded. This study was approved by our institutional ethical committee.